Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones


ABSTRACT: KCL-22 is a chronic myeloid leukemia (CML) cell line derived from a patient in blast crisis phase and harbors the BCR-ABL translocation. The catalytic (ATP-competitive) BCR-ABL inhibitors imatinib and nilotinib have dramatically improved CML patient outcome, but the development of resistance remains a clinical challenge. The recent identification of allosteric BCR-ABL inhibitors, such as GNF-2, which target the enzyme by binding to the myristoyl pocket rather than catalytic site of ABL1, may provide a strategy to broadly overcome resistance to the class of ABL1 ATP competitive inhibitors. We therefore wanted to use the ClonTracer barcoding system to compare the clonal responses of KCL-22 to imatinib, nilotinib and GNF-2. RNA-seq was employed to characterize genetic alterations and gene expression signatures in the pooled cell populations resistant to BCR-ABL inhibitors as well as single clones showing differential response to the three inhibitors. mRNA profiling of the subpopulations and single clones of human CML cell line KCL-22 that contribute to BCR-ABL inhibitor resistance

ORGANISM(S): Homo sapiens

SUBMITTER: Joshua Korn 

PROVIDER: E-GEOD-62121 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2014-10-07 | GSE62121 | GEO
2009-12-19 | GSE19567 | GEO
2010-01-19 | E-GEOD-19567 | biostudies-arrayexpress
2020-05-26 | GSE132666 | GEO
2010-07-15 | E-GEOD-21499 | biostudies-arrayexpress
2009-04-25 | E-GEOD-7114 | biostudies-arrayexpress
2023-05-03 | GSE218451 | GEO
2016-01-26 | GSE60315 | GEO
2010-07-15 | GSE21499 | GEO
2019-04-17 | GSE119770 | GEO